MORPHOLOGICAL CHANGES IN ALL MORPHOFUNCTIONAL ZONES OF TRACHEOBRONCHIAL LYMPH NODES UNDER THE INFLUENCE OF PREECLAMPSIA
Keywords:
preeclampsia, tracheobronchial lymph nodes, immunopathogenesisAbstract
This study comprehensively investigates the morphological and morphometric changes occurring in the morphofunctional zones of tracheobronchial lymph nodes under conditions of preeclampsia.
In the pathogenesis of preeclampsia, the immunological conflict between the mother and the fetus plays a leading role. This is characterized by the entry of fetal (primarily paternal) antigens into the maternal bloodstream and the subsequent formation of antigen–antibody complexes.
In normal pregnancy, mechanisms of immune tolerance—particularly those mediated by the T-suppressor system—help to eliminate this conflict. However, insufficient functioning of these mechanisms leads to an усиление иммунопатологических реакций, placental damage, and the development of preeclampsia.
References
1. М.П. Курочка, О. В. Гайда, И. А. Евдокимова Клинико-морфологический анализ случаев материнских смертей от преэклампсии и эклампсии по данным ростовского областного патолого-анатомического бюро Кубанский научный медицинский вестник № 5 (128) 2011 с. 85-89.
2. Сидорова И.С., Никитина Н.А., Гусева Е.В. Результаты конфиденциального аудита материнской смертности от преэклампсии и эклампсии в России в 2017–2018 гг. Акушерство и Гинекология 2020 №1 с. 119-127.
3. Ziadie MS. Toxemia of pregnancy (preeclampsia and eclampsia). PathologyOutlines.comwebsite. https://www.pathologyoutlines.com/topic/ placentatoxemia.html. Accessed August 13th, 2020
4. E. Weiner, Y. Mizrachi, E. Grinstein et al., “The role of placental histopathological lesions in predicting recurrence of preeclampsia,” Prenatal Diagnosis, vol. 36, no. 10, pp. 953–960, 2016.
5. G. Lambert, J. F. Brichant, G. Hartstein, V. Bonhomme, and P. Y. Dewandre, “Preeclampsia: an update,” Acta Anaesthesiologica Belgica, vol. 65, no. 4, pp. 137–149, 2014
6. K.Ramesh, S. Gandhi, and V. Rao, “Socio-demographic and other risk factors of pre eclampsia at a tertiary care hospital, Karnataka: case control study,” Journal of Clinical and Diagnostic Research, vol. 8, no. 9, pp. JC01–JC014, 2014.
7. Yusrawati, N. P. K. Saputra, N. I. Lipoeto, and R. Machmud, “Analyses of nutrients and body mass index as risk factor for preeclampsia,” Journal of Obstetrics and Gynecology of India, vol. 67, no. 6, pp. 409–413, 2017.
8. Rui-Qi Chang, Wen-Jie Zhou, Da-Jin Li, Ming-Qing Li / Innate Lymphoid Cells at the Maternal-Fetal Interface in Human Pregnancy Int J Biol Sci 2020; 16(6):957-969. doi:10.7150/ijbs.38264
9. M. Kovo, L. Schreiber, O. Elyashiv, A. Ben-Haroush, G. Abraham, and J. Bar, “Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia,” Reproductive Sciences, vol. 22, no. 3, pp. 316–321, 2015.
10. Дубовой, А.А. Перспективы изучения биомаркеров-предикторов развития гестоза и его осложнений / А.А. Дубовой // Вестник молодого ученого. – 2012. – Ставрополь. - № 1. – С. 34-39.
11. Procopciuc LM, et al. Maternal/newborn VEGF-C936T interaction and its influence on the risk, severity and prognosis of preeclampsia, as well as on the maternal angiogenic profile. J Matern Fetal Neonatal Med. 2014;27(17):1754–60.
